Cairo - Mubasher: The rights issue of Macro Group Pharmaceuticals achieved 99% oversubscription during the period from 18 November until 3 December 2025.
The capital increase process registered subscription in 2.82 billion new ordinary shares at a par value of EGP 0.20 per share, according to a bourse filing.
Following the EGP 570.20 million worth of rights issue value, the group's capital will stand at EGP 684.24 million.
In October 2025, Macro Group’s extraordinary general meeting approved increasing the company’s issued capital from EGP 114.04 million.
